Access Program for Healthcare Professionals

Harmony is available to all women — regardless of insurance coverage. Using Harmony in your practice may help minimize follow-up diagnostic testing and the associated complications. Harmony gives all women clear answers to questions that matter.

Many insurance plans include coverage of the Harmony Prenatal Test.
In addition, Harmony offers various assistance programs to help provide access to patients:


Patient Protection

Limits the patients out of pocket cost if the insurance plans determines the Harmony Prenatal Test a non-covered service.


Financial Assistance

For expectant parents with a financial need. Ariosa Diagnostics offers assistance to those who qualify based on a sliding fee schedule.


Prompt Pay

For expectant parents who pay their bill within 30 days, Ariosa Diagnostics offers a program that offers discounted pricing.


Payment Plan

Expectant parents can arrange to make payments of a specific amount of time.

For more information on these programs,
please call 1-855-927-4672


A unique test with a unique billing code.

The Harmony Prenatal Test has a Category 1 MAAA CPT code. This code is unique to Harmony and should facilitate reimbursement from third party payers. For testing options that include X and Y chromosomes analysis additional coding is necessary.

Harmony Test – 81507
Additional testing options – 81599

Additional testing options:

Fetal Sex (singleton and twins)
Monosomy X (singleton only)
Sex chromosomes aneuploidy panel (singleton only)
22q11.2 (singleton only)

The Harmony Prenatal Test has been validated for use in twins and IVF pregnancies, including self and non-self egg donor pregnancies.
22q.11.2 testing is not available to women that are known to have this deletion.1

For more information please
call 1-855-927-4672


Note: The Harmony Access Program is only available in the United States and U.S. Territories.

1. Gil et al. Fetal Diagn Ther. 2014;35:204-11.

The Harmony Prenatal Test was developed by Ariosa Diagnostics, a CLIA-certified laboratory. As with other lab-developed tests, it has not been cleared or approved by the FDA and is not available for sale as an IVD in the US. Non-invasive prenatal testing (NIPT) based on cell-free DNA analysis is not diagnostic; results should be confirmed by diagnostic testing.